Myanmar presents specific health challenges that require preparation months before arrival. The country lies almost entirely within malaria-endemic zones, with varying transmission risks across different regions. Hepatitis A and typhoid fever remain common throughout Myanmar due to inconsistent water treatment and sanitation infrastructure. Japanese encephalitis occurs in rural agricultural areas, particularly during the monsoon season from May to October. Dengue fever transmission peaks during the rainy months, with outbreaks reported annually in urban centers including Yangon and Mandalay.
Malaria transmission occurs year-round across most of Myanmar, with lower risk in areas above 1,000 meters elevation. The Kayah State, Kayin State, Shan State along borders with Thailand, Kachin State near the Chinese border, and Tanintharyi Region along the Andaman Sea coastline all report active transmission. Chloroquine-resistant Plasmodium falciparum is present throughout Myanmar, making standard prophylaxis ineffective. Mefloquine resistance has been documented in eastern border regions. The Centers for Disease Control lists Myanmar in its highest-risk category for malaria. Naypyidaw, Yangon, and Mandalay city centers generally fall below threshold transmission levels, though suburban and periurban areas may maintain active mosquito populations. Bagan Archaeological Zone sits in a lower transmission area due to its central dry zone location, but visitors to Inle Lake in Shan State enter active transmission zones.
The United States CDC recommends atovaquone-proguanil, doxycycline, or tafenoquine for travelers to Myanmar's endemic regions. Tafenoquine requires G6PD testing before prescription due to hemolysis risk in deficient individuals. Primaquine serves as an alternative for shorter stays. No prophylaxis provides complete protection, requiring continued mosquito avoidance measures. Prophylaxis typically begins one to two days before entry depending on the medication, continues throughout the stay, and extends four weeks after departure for most regimens. Tafenoquine requires only a single post-travel dose. These medications require prescriptions in most countries and should be obtained before departure, as counterfeit antimalarials circulate in Myanmar's pharmaceutical supply chain.
The yellow fever vaccine is not required for Myanmar unless arriving from a country with active transmission. Myanmar does not appear on the WHO list of countries with endemic yellow fever risk. Travelers arriving directly from the Americas or sub-Saharan Africa within specific timeframes may face vaccination requirements at ports of entry.
Routine vaccinations require verification before travel to Myanmar. The CDC recommends ensuring current status for measles-mumps-rubella after multiple measles outbreaks occurred in Myanmar from 2018 through 2023. The country reported 2,287 measles cases in 2019 before the COVID-19 pandemic disrupted surveillance systems. Diphtheria-tetanus-pertussis vaccination should be current, with tetanus boosters administered every ten years. Polio vaccination receives particular emphasis for Myanmar, as the country reported vaccine-derived poliovirus type 2 circulation in 2019 in Kayin State and Yangon Region. Adults who completed childhood polio vaccination series should receive a single adult booster before travel to Myanmar.
Hepatitis A vaccination requires two doses administered six months apart for complete protection, though a single dose provides substantial immunity for travelers departing before completing the series. Hepatitis A transmits through contaminated food and water throughout Myanmar, with particularly high risk in areas lacking piped water systems. The Irrawaddy Delta, where river flooding regularly compromises water sources, reports consistent hepatitis A incidence. Street food in markets across Yangon, Mandalay, and Mawlamyine presents documented transmission risk. Hepatitis A antibody testing before vaccination can identify those with existing immunity from prior exposure, eliminating unnecessary vaccination costs.
Typhoid vaccination exists in two forms: an injectable polysaccharide vaccine providing protection for two years, and an oral live attenuated vaccine requiring four capsules taken on alternate days providing protection for five years. Typhoid fever occurs throughout Myanmar, transmitted through contaminated water and food. The oral vaccine requires completion at least one week before potential exposure and cannot be administered to immunocompromised individuals or those taking antibiotics. Both vaccines provide only 50 to 80 percent protection, requiring continued food and water precautions. Multi-drug resistant typhoid strains have been isolated in Myanmar, though comprehensive surveillance data remains limited.
Japanese encephalitis vaccination merits consideration based on specific itinerary details and season. The disease transmits through Culex mosquitoes that breed in rice paddies and pig farming areas. Transmission peaks during monsoon months from May through October when mosquito populations expand. The Ayeyarwady Delta, the rice-growing regions of Bago Region and Sagaing Region, and areas around Inle Lake all maintain suitable transmission environments. Urban travelers spending limited time in cities face minimal risk. The vaccine requires two doses administered 28 days apart, with the second dose needed at least one week before potential exposure. A two-dose series provides protection for at least one year, with boosters extending coverage. Ixiaro and Jespect are the primary brands available internationally. The vaccine costs between 200 and 400 USD for the two-dose series in most countries.
Rabies vaccination should be considered for certain travelers to Myanmar. The country reports approximately 1,000 human rabies deaths annually, though the actual figure likely exceeds this due to underreporting in rural areas. Stray dogs populate urban centers including Yangon and Mandalay, while monkeys at temple sites including Shwedagon Pagoda and locations throughout Bagan Archaeological Zone regularly interact with visitors. The pre-exposure rabies vaccine series consists of three doses administered on days 0, 7, and 21 or 28. This series does not eliminate the need for post-exposure treatment but reduces the number of doses required and eliminates the need for rabies immunoglobulin, which is frequently unavailable in Myanmar. Post-exposure treatment requires four doses over two weeks for previously vaccinated individuals, versus four to five doses plus immunoglobulin for unvaccinated individuals. Rabies immunoglobulin supplies in Myanmar are unreliable, occasionally requiring medical evacuation to Thailand for treatment.
Healthcare infrastructure in Myanmar concentrates in Yangon and Naypyidaw, with limited capabilities elsewhere. Yangon General Hospital, established in 1899, serves as the country's primary public referral hospital with approximately 1,500 beds. Pun Hlaing Siloam Hospital in Yangon opened in 2014 as a private facility meeting some international standards. Naypyidaw has Naypyidaw General Hospital, though its capabilities remain below those of Yangon facilities. International SOS operates a clinic in Yangon providing care to expatriates and travelers. Outside these centers, medical capabilities decline substantially. Mandalay has several private hospitals, but complex cases typically transfer to Yangon. Bagan has basic clinics only. Inle Lake area has minimal medical infrastructure.
Medical evacuation insurance deserves strong consideration for Myanmar travel. Evacuation to Bangkok, Thailand typically costs 15,000 to 50,000 USD depending on medical staffing requirements and aircraft type. Singapore serves as another common evacuation destination. Myanmar's domestic blood supply carries hepatitis B, hepatitis C, and HIV risk due to inconsistent screening protocols. The country faces periodic shortages of essential medications and medical supplies. Surgical capabilities outside Yangon are limited, with sterility protocols inconsistent. Travel insurance policies should explicitly cover Myanmar, as some policies exclude countries with active conflict zones, and several states in Myanmar have experienced armed conflict since the February 2021 military coup.
Altitude considerations apply only to specific Myanmar destinations. Hkakabo Razi reaches 5,881 meters but is accessible only through extended mountaineering expeditions requiring permits rarely granted. Mount Victoria in Natmataung National Park reaches 3,094 meters, where acute mountain sickness can occur in susceptible individuals. The town of Pyin Oo Lwin sits at approximately 1,070 meters, below altitudes typically causing symptoms. The Shan Plateau averages 1,000 to 1,300 meters elevation, with Inle Lake at approximately 880 meters and Taunggyi at 1,430 meters. Acute mountain sickness typically begins affecting susceptible individuals above 2,500 meters, though individual variation exists.